This is from the Announcement "A PRV grants the holder an expedited six-month review of a new drug application by FDA. PRVs can be sold to other companies and have historically commanded prices between US$68 million and US$350 million"
A PRV from the FDA to fast track the review.
- Forums
- ASX - By Stock
- KZA
- Across the pond...Nasdaq: KZIA
Across the pond...Nasdaq: KZIA, page-119
-
- There are more pages in this discussion • 152 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online